Authorized purpose: The Philips CT 3500 produces CT images of the head and body and is indicated for head, whole-body, cardiac-calcium-scoring, and vascular CT in patients of all ages; it is also labeled for low-dose CT lung-cancer screening within established governmental or professional-society program criteria.
Clinical role
X-ray CT acquisition and reconstruction, with release-specific image-quality, spectral, or deep-learning processing functions where labeled.
Images and patients
CT/CTA · Head, whole body, cardiac, vascular, and lung-screening anatomy
Key limitation
Keep in mind: Use only the exact labeled scanner, software, dose, reconstruction, patient population, anatomy, and screening criteria; local dose and image-quality decisions remain clinical responsibilities.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: The Philips CT 3500 produces CT images of the head and body and is indicated for head, whole-body, cardiac-calcium-scoring, and vascular CT in patients of all ages; it is also labeled for low-dose CT lung-cancer screening within established governmental or professional-society program criteria.
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Head, whole body, cardiac, vascular, and lung-screening anatomy Input: X-ray transmission data acquired with the exact labeled CT system, protocols, software, and hardware.
Who uses it?Intended users: Qualified radiologic technologists and physicians or other trained healthcare professionals within the labeled workflow.
What does the software produce?Output: Cross-sectional CT images, volume sets, and labeled reconstructed or processed image outputs for professional review.
What is its most important limitation?Key limitation: Use only the exact labeled scanner, software, dose, reconstruction, patient population, anatomy, and screening criteria; local dose and image-quality decisions remain clinical responsibilities.
Clinical takeaway. Clinical role: The Philips CT 3500 produces CT images of the head and body and is indicated for head, whole-body, cardiac-calcium-scoring, and vascular CT in patients of all ages; it is also labeled for low-dose CT lung-cancer screening within established governmental or professional-society program criteria.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports non-clinical testing: design verification, design validation (including workflow validation) and consensus standards tests, and an image quality metric comparison with the predicate device; test results met the acceptance criteria. It states the Philips CT 3500 did not require clinical study. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
The Philips CT 3500 produces CT images of the head and body and is indicated for head, whole-body, cardiac-calcium-scoring, and vascular CT in patients of all ages; it is also labeled for low-dose CT lung-cancer screening within established governmental or professional-society program criteria.
Use only the exact labeled scanner, software, dose, reconstruction, patient population, anatomy, and screening criteria; local dose and image-quality decisions remain clinical responsibilities.
The exact FDA document reports non-clinical testing: design verification, design validation (including workflow validation) and consensus standards tests, and an image quality metric comparison with the predicate device; test results met the acceptance criteria. It states the Philips CT 3500 did not require clinical study. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The systems performed a comparison to the predicate device using these technological characteristics and image quality metrics to establish that the subject device is substantially equivalent to the predicate device for its intended use." … "The systems pass the design verification, design validation and consensus standards test as nonclinical tests.". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports non-clinical testing: design verification, design validation (including workflow validation) and consensus standards tests, and an image quality metric comparison with the predicate device; test results met the acceptance criteria. It states the Philips CT 3500 did not require clinical study. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "The systems performed a comparison to the predicate device using these technological characteristics and image quality metrics to establish that the subject device is substantially equivalent to the predicate device for its intended use." … "The systems pass the design verification, design validation and consensus standards test as nonclinical tests.". Read from the exact FDA decision document on 2026-11-14.
No exact-submission and version-linked sensitivity endpoint is promoted; candidate or product-family values were not substituted.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No exact-submission and version-linked specificity endpoint is promoted; candidate or product-family values were not substituted.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
FDA submission-specific verification and validation evidence for K223311
DesignFDA 510(k) regulatory decision material and submission-specific verification or validation evidence for K223311; this is regulatory evidence, not an independent clinical effectiveness study.
PopulationThe labeled population, anatomy, images, and test materials described in the exact FDA decision material for K223311; a broader clinical population is not established here.
Scopeexact submission
Tested versionPhilips CT 3500 (K223311)
IndependenceSponsor or vendor study
K223311
The exact FDA material is submission-specific and should not be generalized to other versions, enabled options, sites, protocols, or clinical outcomes.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: X-ray transmission data acquired with the exact labeled CT system, protocols, software, and hardware.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact FDA package describes DICOM communication compliance, a Worklist that displays patient information provided by the HIS/RIS, and patient study-status feedback that can be sent to the hospital HIS/RIS. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "Communication Compliance with Compliance with Identical. DICOM DICOM Therefore," … "Worklist The Worklist displays patient Yes Identical. information provided by the Therefore, HIS/RIS.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. Exact deployment topology, hosting, network boundaries, PHI flow, retention, update mechanism, and local operational requirements are not established for this submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-04 ·
Returned objects
Source context, not route validation: Cross-sectional CT images, volume sets, and labeled reconstructed or processed image outputs for professional review.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Cross-sectional CT images, volume sets, and labeled reconstructed or processed image outputs for professional review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes DICOM communication compliance, a Worklist that displays patient information provided by the HIS/RIS, and patient study-status feedback that can be sent to the hospital HIS/RIS. Interface versions and local compatibility require confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Communication Compliance with Compliance with Identical. DICOM DICOM Therefore," … "Worklist The Worklist displays patient Yes Identical. information provided by the Therefore, HIS/RIS.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Philips' Responsible Disclosure Statement states that Philips maintains a global network of product security officers for developing and deploying security and privacy features for its products and services and for managing security events; that vulnerability reports to productsecurity@philips.com (PGP-encrypted) are acknowledged within two business days with a tracking number and an assigned contact; status updates approximately every 2-3 weeks; a 90-day resolution aim; and patch or advisory notification through existing customer notification processes. Vendor statement; no certification or test report was read.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: the statement is on philips.com (Royal Philips) and covers Philips products and services; the FDA applicant entity appears in Philips' own BCR members list on documents.philips.com (Philips Ultrasound LLC, Philips Medical Systems Nederland B.V., Philips Healthcare (Suzhou), Philips Medical Systems DMC GmbH, Philips Medical Systems Technologies Ltd., Philips Oy). Corporate policy; exact-release scope is not established.
Philips' coordinated vulnerability disclosure policy states a global product security officer network, PGP-based reporting, acknowledgement within 2 business days, report tracking, updates every 2-3 weeks, a 90-day resolution aim and customer notification.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The policy names Philips generally and does not scope these commitments to any specific product release; exact-release scope is not established.
Current vendor material is product-family context for K223311 only; exact release, enabled options, deployment, security, interoperability, pricing, and local workflow require confirmation.
product family · checked 2026-09-04
Vendor material is not exact-release evidence unless that linkage is separately proven.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
31Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, implementation documentation, reimbursement policy, peer reviewed literature, clinical trial registry, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public exact-release price, license fee, subscription, contract, or implementation cost was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not applicable - checked 2026-09-04 - Not applicable
CMS coverage-index context was checked, but no product-specific coverage or reimbursement determination is inferred.
Deployment: Not publicly available - checked 2026-09-04 - Exact FDA submission
Exact deployment topology, hosting, network boundaries, PHI flow, retention, update mechanism, and local operational requirements are not established for this submission.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Authorized purpose: uCT ATLAS Astound is a computed-tomography X-ray system that produces cross-sectional images of the whole body and is applicable to head, whole-body, cardiac, and vascular CT; it is also labeled for low-dose CT lung-cancer screening within approved governmental or professional-society programs, and its uWS-CT-Dual Energy Analysis package processes paired UIH CT images acquired at different tube voltages or currents to visualize material information.
Modality
CT/CTA
Anatomy
Head, whole body, cardiac, vascular, and lung-screening anatomy
Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.